Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-43

"Its looking like a tough year ahead globally so expect challenges along the way. 2024/25 is hopefully looking better for everyone." (sic)

Honestly, I read every post that you have made on this thread regarding this latest financial report. It is difficult to ascertain whether you intend to offer serious (even lucid) commentary on the topic. Did you read the report?

Revenue at 54k is lower than the average wage! You know that some on the BOD are getting paid $312,000 to produce laughable results like those in this latest report.

What exactly is in that report that a reasonable shareholder would find acceptable?

And the response to legitimate questions and points to is "... all the questions are answered in the report".

And exactly what data are you in possession of that enables you to conclude that a counterclaim against Medcan is a good "strategy"?

The mind boggles.